Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA: A Cancer J Clin. 2018;68(6):394–424.
Google Scholar
Mohammadian M, Soroush A, Mohammadian-Hafshejani A, et al. Incidence and mortality of liver cancer and their relationship with development in Asia [J]. Asian Pacific J Cancer Prev. 2016;17(4):2041–7.
Article
Google Scholar
Mak D, Sengayi M, Chen WC, et al. Liver cancer mortality trends in South Africa: 1999–2015[J]. BMC Cancer. 2018;18(1):798.
Article
Google Scholar
Feng R-M, Zong Y-N, Cao S-M, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?[J]. Cancer Commun. 2019;39(1):22.
Article
Google Scholar
Zhou J, Sun H-C, Wang Z, et al. Guidelines for diagnosis and treatment of primary liver cancer in China (2017 Edition)[J]. Liver Cancer. 2018;7(3):235–60.
Article
Google Scholar
Jones DC, Kosmoliaptsis V, Apps R, et al. HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding [J]. J Immunol. 2011;186(5):2990.
Article
CAS
Google Scholar
Wang L, Fan J, Ye W, Han J, Zhang Y, Zhao L, Duan J, Yin D, Yi Y. The expression of ILT4 in myeloid dendritic cells in patients with hepatocellular carcinoma. Immunol Invest. 2019;48(7):704–18.
Burshtyn DN, Morcos C. The expanding spectrum of ligands for leukocyte Ig-like receptors [J]. J Immunol. 2016;196(3):947.
Article
CAS
Google Scholar
Young NT, Waller ECP, Patel R, et al. The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells [J]. Blood. 2008;111(6):3090–6.
Article
CAS
Google Scholar
Chen H, Chen Y, Deng M, et al. Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells [J]. J Immunother Cancer. 2020;8(2):e000515.
Article
Google Scholar
Jones DC, Hewitt CRA, López-Álvarez MR, Jahnke M, Russell AI, Radjabova V, Trowsdale ARZ, Trowsdale J. Allele-specific recognition by LILRB3 and LILRA6 of a cytokeratin 8-associated ligand on necrotic glandular epithelial cells. Oncotarget. 2016;7(13):15618.
Hogan LE, Jones DC, Allen RL. Expression of the innate immune receptor LILRB5 on monocytes is associated with mycobacteria exposure [J]. Sci Rep. 2016;6(1):21780.
Article
CAS
Google Scholar
Yeboah M, Papagregoriou C, Jones DC, et al. LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation [J]. JCI Insight. 2020;5(18):e141593.
Article
Google Scholar
Kang X, Kim J, Deng M, et al. Inhibitory leukocyte immunoglobulin-like receptors: immune checkpoint proteins and tumor sustaining factors [J]. Cell Cycle. 2016;15(1):25–40.
Article
CAS
Google Scholar
Wiśniewski A, Kowal A, Wyrodek E, et al. Genetic polymorphisms and expression of HLA-G and its receptors, KIR2DL4 and LILRB1, in non-small cell lung cancer [J]. Tissue Antigens. 2015;85(6):466–75.
Article
Google Scholar
Cheng J, Luan J, Chen P, et al. Immunosuppressive receptor LILRB1 acts as a potential regulator in hepatocellular carcinoma by integrating with SHP1[J]. Cancer Biomarkers. 2020;28:309–19.
Article
CAS
Google Scholar
Liu X, Yu X, Xie J, et al. ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells [J]. Oncotarget. 2015;6(25):21004–15.
Article
Google Scholar
Zhang P, Guo X, Li J, et al. Immunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signaling pathway in non-small cell lung cancer [J]. Oncotarget. 2015;6(15):13550–63.
Article
Google Scholar
John S, Chen H, Deng M, et al. A novel anti-LILRB4 CAR-T cell for the treatment of monocytic AML [J]. Mole Therapy. 2018;26(10):2487–95.
Article
CAS
Google Scholar
Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses [J]. Nucleic Acids Res. 2017;45(W1):W98–W102.
Article
CAS
Google Scholar
Nagy LA, Menyhárt O, et al. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets [J]. Sci Rep. 2018;8(1):9227.
Article
Google Scholar
Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells [J]. Cancer Res. 2017;77(21):e108–10.
Article
CAS
Google Scholar
Ru B, Wong CN, Tong Y, et al. TISIDB: an integrated repository portal for tumor–immune system interactions [J]. Bioinformatics. 2019;35(20):4200–2.
Article
CAS
Google Scholar
Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets [J]. Nucleic Acids Res. 2018;47(D1):D607–13.
Article
Google Scholar
Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources [J]. Nat Protoc. 2009;4(1):44–57.
Article
CAS
Google Scholar
Pirker R, Pereira JR, Von Pawel J, et al. EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study [J]. Lancet Oncol. 2012;13(1):33–42.
Article
CAS
Google Scholar
Wurmbach E, Chen Y-B, Khitrov G, et al. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma [J]. Hepatology. 2007;45(4):938–47.
Article
CAS
Google Scholar
Roessler S, Jia H-L, Budhu A, et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients [J]. Cancer Res. 2010;70(24):10202.
Article
CAS
Google Scholar
Mas VR, Maluf DG, Archer KJ, et al. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma [J]. Mole Med (Cambridge, Mass.). 2009;15(3-4):85–94.
CAS
Google Scholar
Chen X, Cheung ST, So S, et al. Gene expression patterns in human liver cancers [J]. Mole Biol Cell. 2002;13(6):1929–39.
Article
CAS
Google Scholar
Yao W, He J-C, Yang Y, et al. The prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma: a systematic review and meta-analysis [J]. Sci Rep. 2017;7(1):7525.
Article
Google Scholar
Gu X, Laouar A, Wan J, et al. The gp49B1 inhibitory receptor regulates the IFN-γ responses of T cells and NK cells [J]. J Immunol. 2003;170(8):4095.
Article
CAS
Google Scholar
Si YQ, Bian XK, Lu N, et al. Cyclosporine induces up-regulation of immunoglobulin-like transcripts 3 and 4 expression on and activity of NKL cells [J]. Transplant Proc. 2012;44(5):1407–11.
Article
CAS
Google Scholar
Jin Z, Fan J, Zhang Y, et al. Comparison of morphology, phenotypes and function between cultured human IL4DC and IFNDC [J]. Mol Med Rep. 2017;16(5):7345–54.
Article
CAS
Google Scholar
Vujanovic L, Chuckran C, Lin Y, Ding F, Sander CA, Santos PM, Lohr J, Mashadi-Hossein A, Warren S, White A. CD56dim CD16− natural killer cell profiling in melanoma patients receiving a cancer vaccine and interferon-α. Front Immunol. 2019;10:14.
Barkal AA, Weiskopf K, Kao KS, et al. Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy [J]. Nat Immunol. 2018;19(1):76–84.
Article
CAS
Google Scholar
Li Q, Li J, Wang S, et al. Overexpressed immunoglobulin-like transcript (ILT) 4 in lung adenocarcinoma is correlated with immunosuppressive T cell subset infiltration and poor patient outcomes [J]. Biomarker Res. 2020;8:11.
Article
CAS
Google Scholar
Li X, Wei X, Xu H, et al. Expression of leukocyte immunoglobulin-like receptor B2 in hepatocellular carcinoma and its clinical significance [J]. J Cancer Res Therapeut. 2018;14(7):1655–9.
Article
CAS
Google Scholar
Thommen DS, Schumacher TN. T cell dysfunction in cancer [J]. Cancer cell. 2018;33(4):547–62.
Article
CAS
Google Scholar
Endo S, Sakamoto Y, Kobayashi E, et al. Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells [J]. Proc National Acad Sci. 2008;105(38):14515–20.
Article
CAS
Google Scholar
Chen H-M, Van Der Touw W, Wang YS, et al. Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity [J]. J Clin Invest. 2018;128(12):5647–62.
Article
Google Scholar
Hoechst B, Voigtlaender T, Ormandy L, et al. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor [J]. Hepatology. 2009;50(3):799–807.
Article
CAS
Google Scholar
Amand M, Iserentant G, Poli A, Sleiman M, Fievez V, Sanchez IP, Sauvageot N, Michel T, Aouali N, Janji B. Human CD56dimCD16dim cells as an individualized natural killer cell subset. Front Immunol. 2017;8:699.
Cai L, Zhang Z, Zhou L, et al. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients [J]. Clin Immunol. 2008;129(3):428–37.
Article
CAS
Google Scholar